Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
AstraZeneca
Chubb
Express Scripts
Healthtrust
Cerilliant
Colorcon
Covington

Generated: December 13, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for BREO ELLIPTA

« Back to Dashboard

Payment Methods and Pharmacy Types for BREO ELLIPTA (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $10,805,071
INSIDE ANOTHER STORE $152,174,819
[disabled in preview] $848,809,539
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 43,981
INSIDE ANOTHER STORE 498,450
[disabled in preview] 1,730,731
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $49,139,143
MEDICARE $522,334,390
[disabled in preview] $440,315,896
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for BREO ELLIPTA
Drug Units Sold Trends for BREO ELLIPTA

Annual Sales Revenues and Units Sold for BREO ELLIPTA

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2016
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2015
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2014
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2013
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2012
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2011
BREO ELLIPTA ➤ Try a Free Trial ➤ Try a Free Trial 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Citi
QuintilesIMS
Dow
Express Scripts
Accenture
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.